Lupin per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹121.01₹116.75₹71.95₹42.05₹9.46
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹120.73₹116.44₹71.69₹41.87₹9.41
₹490.99₹490.99₹376.77₹313.59₹273.95
₹655.44₹611.51₹497.33₹439.12₹365.75
—₹165.04₹9.42₹76.59₹42.51
₹120.10₹120.10−₹27.43₹56.21₹9.55
—₹11.99₹8.00₹4.01₹4.01
45.745.745.745.645.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

LUPIN₹1,972.70

Lupin Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMACIPLADRREDDYALKEMFORTISAUROPHARMALAURUSLABSMANKINDMcap ₹90,192 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS9.4642.0571.95116.75121.01
Diluted EPS9.4141.8771.69116.44120.73
Book Value per Share273.95313.59376.77490.99490.99
Revenue per Share365.75439.12497.33611.51655.44
Cash Flow per Share42.5176.599.42165.04—
Free Cash Flow per Share9.5556.21-27.43120.10120.10
Dividends per Share4.014.018.0011.99—
Shares Outstanding (cr)45.545.645.745.745.7
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.